Saturn V Capital Management LP Diversified Active

Location: Austin, TX

CIK: 0001964437 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 14, 2025

Total Value: $255M (100.0% shares, 0.0% debt)

Holdings (24)

IRON DISC MEDICINE INC 12.6%
Value $32.3M Shares 509,406 Est. Cost $47.84 Unrealized +20.9%
ASND ASCENDIS PHARMA A/S 10.7%
Value $27.39M Shares 198,977 Est. Cost $128.89 Unrealized
MLTX MOONLAKE IMMUNOTHERAPEUTICS 7.3%
Value $18.74M Shares 346,111 Est. Cost $47.43 Unrealized +7.6%
CGON CG ONCOLOGY INC 6.7%
Value $17.01M Shares 593,262 Est. Cost $34.95 Unrealized -2.1%
PCVX VAXCYTE INC 6.5%
Value $16.72M Shares 204,285 Est. Cost $69.08 Unrealized +43.7%
CYTK CYTOKINETICS INC 6.4%
Value $16.39M Shares 348,364 Est. Cost $43.27 Unrealized +20.0%
CARGO THERAPEUTICS INC 5.7%
Value $14.53M Shares 1,007,677 Est. Cost $16.71 Unrealized
CELC CELCUITY INC 5.5%
Value $13.92M Shares 1,063,783 Est. Cost $16.40 Unrealized -13.9%
SNDX SYNDAX PHARMACEUTICALS INC 5.1%
Value $13.07M Shares 988,528 Est. Cost $18.38 Unrealized -6.9%
XENE XENON PHARMACEUTICALS INC 5.0%
Value $12.64M Shares 322,470 Est. Cost $41.35 Unrealized 0.0%
ARGX ARGENX SE 4.8%
Value $12.15M Shares 19,754 Est. Cost $394.09 Unrealized
COGT COGENT BIOSCIENCES INC 4.6%
Value $11.69M Shares 1,498,425 Est. Cost $8.73 Unrealized +14.2%
MERUS N V 3.9%
Value $9.866M Shares 234,637 Est. Cost $33.69 Unrealized
CTNM CONTINEUM THERAPEUTICS INC 3.3%
Value $8.395M Shares 573,022 Est. Cost $15.90 Unrealized -0.4%
ABVX ABIVAX SA 1.9%
Value $4.78M Shares 653,071 Est. Cost $14.21 Unrealized
KALV KALVISTA PHARMACEUTICALS INC 1.8%
Value $4.713M Shares 556,489 Est. Cost $7.51 Unrealized +37.9%
INOZYME PHARMA INC 1.5%
Value $3.808M Shares 1,374,582 Est. Cost $4.59 Unrealized
IRWD IRONWOOD PHARMACEUTICALS INC 1.4%
Value $3.608M Shares 814,533 Est. Cost $11.37 Unrealized -64.3%
AMLX AMYLYX PHARMACEUTICALS INC 1.3%
Value $3.361M Shares 889,073 Est. Cost $4.71 Unrealized 0.0%
CRNX CRINETICS PHARMACEUTICALS IN 1.2%
Value $3.023M Shares 59,125 Est. Cost $18.62 Unrealized +200.5%
SLN SILENCE THERAPEUTICS PLC 1.1%
Value $2.718M Shares 395,024 Est. Cost $18.18 Unrealized
NAMS NEWAMSTERDAM PHARMA COMPANY 1.0%
Value $2.57M Shares 100,000 Est. Cost $21.24 Unrealized 0.0%
OCUL OCULAR THERAPEUTIX INC 0.6%
Value $1.635M Shares 191,456 Est. Cost $9.76 Unrealized 0.0%
MBX MBX BIOSCIENCES INC 0.1%
Value $332K Shares 18,000 Est. Cost $21.31 Unrealized 0.0%